Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HLA-G |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → HLA-G |
| (<<) SLAMF8 → HLA-G |
| (<<) HCP5 → HLA-G |
| (<<) CCL3L3///CCL3L1///CCL3 → HLA-G |
| (<<) TAP1 → HLA-G |
| (<<) HLA-F → HLA-G |
| (<<) HLA-C → HLA-G |
| Downstream (Children) |
|---|
| HLA-G → CXCL11 (>>) |
| HLA-G → TRIM9 (>>) |
| HLA-G → ZNF444 (>>) |
| HLA-G → HCP5 (>>) |
| HLA-G → HHIPL2 (>>) |
| HLA-G → TAP1 (>>) |
| HLA-G → HLA-F (>>) |
| HLA-G → HLA-C (>>) |
